FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

P & L Developments Cetirizine Oral Solution 1 mg/mL Recall

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Fl…

P & L Developments, LLC · Westbury, NY

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1408-2019
Check your lot numberHow we source this data

Summary

P & L Developments recalled Cetirizine Oral Solution 1 mg/mL starting Jun 5, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1408-2019 on Jun 26, 2019. Reason: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii). Status: Terminated.

Why it was recalled

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Product description

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.

Lot numbers, UPCs & expiration codes

Lot #s: C04866; C09863, Exp. 10/19; F01267, Exp. 12/19; F12609, Exp. 2/20; F25327, Exp. 8/20.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1408-2019
Classification
Class II
Status
Terminated
Recall initiated
Jun 5, 2019
FDA report date
Jun 26, 2019
Quantity
17,664 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
P & L Developments, LLC

Original FDA data

Every field from FDA enforcement report D-1408-2019, exactly as published.

Show all FDA fields
City
Westbury
State
NY
Status
Terminated
Country
United States
Event ID
83181
Address
200 Hicks St
Code information
Lot #s: C04866; C09863, Exp. 10/19; F01267, Exp. 12/19; F12609, Exp. 2/20; F25327, Exp. 8/20.
Postal code
11590-3323
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1408-2019
Classification
Class II
Recalling firm
P & L Developments, LLC
Product quantity
17,664 bottles
Termination date
Sep 9, 2020
Reason for recall
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Jun 5, 2019
Initial firm notification
Letter
Center classification date
Jun 20, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1408-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls